| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 259,900 | Aug 22, 2019, 06:01 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 262,172 | May 22, 2019, 06:07 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Mar 04, 2019 | Sale | $25.06 | 3,343 | 83,764 | 270,134 | Mar 06, 2019, 07:20 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Mar 05, 2019 | Sale | $24.50 | 5,690 | 139,405 | 264,444 | Mar 06, 2019, 07:20 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2019 | Option Exercise | $27.00 | 3,770 | 101,790 | 273,477 | Feb 22, 2019, 06:15 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2018 | Option Exercise | $24.79 | 4,063 | 100,722 | 164,997 | Nov 21, 2018, 05:44 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2018 | Option Exercise | $26.95 | 5,198 | 140,086 | 169,060 | Aug 22, 2018, 07:33 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2018 | Option Exercise | $24.31 | 19,103 | 464,394 | 174,258 | May 22, 2018, 07:01 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2018 | Option Exercise | $29.09 | 4,349 | 126,512 | 159,611 | Feb 22, 2018, 05:39 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2017 | Option Exercise | $28.58 | 5,177 | 147,959 | 154,960 | Nov 22, 2017, 04:38 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2017 | Option Exercise | $27.40 | 5,176 | 141,822 | 160,137 | Aug 22, 2017, 06:28 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2017 | Option Exercise | $36.83 | 5,177 | 190,669 | 165,313 | May 23, 2017, 07:59 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2017 | Option Exercise | $33.78 | 10,138 | 342,462 | 170,490 | Feb 22, 2017, 07:06 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2016 | Option Exercise | $31.96 | 1,845 | 58,966 | 171,628 | Nov 22, 2016, 06:03 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2016 | Option Exercise | $27.89 | 1,846 | 51,485 | 173,473 | Aug 23, 2016, 07:23 PM | |
| TBPH | Theravance Biopharma, Inc. | HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2016 | Option Exercise | $20.55 | 1,846 | 37,935 | 175,319 | May 24, 2016, 07:59 PM |
Menu